Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Craig H Selzman

Showing results (91-100 of 241) with videos related to

Pageof 25
Sort By:
The Journal of Surgical Research|August 16, 2017
Health characteristics of heart transplant recipients surviving into their 80sDeborah R Tabachnick, Megan E Bowen, Josef Stehlik, et al.
Journal of Molecular and Cellular Cardiology|October 9, 2017
Activation of IGF-1 receptors and Akt signaling by systemic hyperinsulinemia contributes to cardiac hypertrophy but does not regulate cardiac autophagy in obese diabetic miceKarla Maria Pires, Marcio Buffolo, Christin Schaaf, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|July 14, 2022
Clinical myocardial recovery in advanced heart failure with long term left ventricular assist device supportManreet K Kanwar, Craig H Selzman, Van-Khue Ton, et al.
BMC Research Notes|January 23, 2021
A pilot trial of human amniotic fluid for the treatment of COVID-19Craig H Selzman, Joseph E Tonna, Jan Pierce, et al.
The Annals of Thoracic Surgery|January 16, 2014
Ventricular assist devices or inotropic agents in status 1A patients? Survival analysis of the United Network of Organ Sharing databaseCurtis J Wozniak, Josef Stehlik, Bradley C Baird, et al.
The Journal of Thoracic and Cardiovascular Surgery|September 23, 2003
Atherogenic effects of Chlamydia pneumoniae: refuting the innocent bystander hypothesisCraig H Selzman, Mihai G Netea, Michael A Zimmerman, et al.
Artificial Organs|October 31, 2009
Experience with the Levitronix CentriMag in the pediatric population as a bridge to decision and recoveryPeter C Kouretas, Aditya K Kaza, Phillip T Burch, et al.
The Journal of Thoracic and Cardiovascular Surgery|January 22, 2009
Regression of pressure-induced left ventricular hypertrophy is characterized by a distinct gene expression profileWilliam E Stansfield, Peter C Charles, Ru-hang Tang, et al.
Journal of Cardiac Failure|October 4, 2022
Interrupted Time Series Analysis of Donor Heart Use Before and After the 2018 UNOS Heart Allocation Policy ChangeAdeline Browne, Holly Gaines, Rami Alharethi, et al.
BMJ Open|February 12, 2021
Safety and feasibility of using acellular sterile filtered amniotic fluid as a treatment for patients with COVID-19: protocol for a randomised, double-blinded, placebo-controlled clinical trialJoseph E Tonna, Jan Pierce, Nathan Hatton, et al.
Pageof 25

Showing results (91-100 of 241) with videos related to

Sort By:
Pageof 25
The Journal of Surgical Research|August 16, 2017
Health characteristics of heart transplant recipients surviving into their 80sDeborah R Tabachnick, Megan E Bowen, Josef Stehlik, et al.
Journal of Molecular and Cellular Cardiology|October 9, 2017
Activation of IGF-1 receptors and Akt signaling by systemic hyperinsulinemia contributes to cardiac hypertrophy but does not regulate cardiac autophagy in obese diabetic miceKarla Maria Pires, Marcio Buffolo, Christin Schaaf, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|July 14, 2022
Clinical myocardial recovery in advanced heart failure with long term left ventricular assist device supportManreet K Kanwar, Craig H Selzman, Van-Khue Ton, et al.
BMC Research Notes|January 23, 2021
A pilot trial of human amniotic fluid for the treatment of COVID-19Craig H Selzman, Joseph E Tonna, Jan Pierce, et al.
The Annals of Thoracic Surgery|January 16, 2014
Ventricular assist devices or inotropic agents in status 1A patients? Survival analysis of the United Network of Organ Sharing databaseCurtis J Wozniak, Josef Stehlik, Bradley C Baird, et al.
The Journal of Thoracic and Cardiovascular Surgery|September 23, 2003
Atherogenic effects of Chlamydia pneumoniae: refuting the innocent bystander hypothesisCraig H Selzman, Mihai G Netea, Michael A Zimmerman, et al.
Artificial Organs|October 31, 2009
Experience with the Levitronix CentriMag in the pediatric population as a bridge to decision and recoveryPeter C Kouretas, Aditya K Kaza, Phillip T Burch, et al.
The Journal of Thoracic and Cardiovascular Surgery|January 22, 2009
Regression of pressure-induced left ventricular hypertrophy is characterized by a distinct gene expression profileWilliam E Stansfield, Peter C Charles, Ru-hang Tang, et al.
Journal of Cardiac Failure|October 4, 2022
Interrupted Time Series Analysis of Donor Heart Use Before and After the 2018 UNOS Heart Allocation Policy ChangeAdeline Browne, Holly Gaines, Rami Alharethi, et al.
BMJ Open|February 12, 2021
Safety and feasibility of using acellular sterile filtered amniotic fluid as a treatment for patients with COVID-19: protocol for a randomised, double-blinded, placebo-controlled clinical trialJoseph E Tonna, Jan Pierce, Nathan Hatton, et al.
Pageof 25